Results 221 to 230 of about 572,756 (326)

Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting β2-agonist bronchodilators [PDF]

open access: hybrid, 2020
NEIL SKOLNIK   +5 more
openalex   +1 more source

The M1 Muscarinic Receptor Antagonist VU0255035 Delays the Development of Status Epilepticus after Organophosphate Exposure and Prevents Hyperexcitability in the Basolateral Amygdala [PDF]

open access: bronze, 2016
Steven L. Miller   +6 more
openalex   +1 more source

A Survey of Physicians' Perceptions About Using Long-Acting Muscarinic Antagonist for Hospitalized COPD Patients [PDF]

open access: bronze, 2020
Shaha Nabeel   +7 more
openalex   +1 more source

Estimated carbon emissions for PBS‐subsidised prescription respiratory inhalers, Australia, 2019–2023: a descriptive analysis

open access: yes
Medical Journal of Australia, Volume 223, Issue 4, Page 214-217, August 2025.
Luise Kazda   +7 more
wiley   +1 more source

Novel long‐acting antagonists of muscarinic ACh receptors [PDF]

open access: hybrid, 2018
Alena Randáková   +4 more
openalex   +1 more source

Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease. [PDF]

open access: yesCochrane Database Syst Rev, 2019
Maqsood U   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy